- Reaction score
- 27
RCH-01 turned out to be $100K - $300K and they have gone silent (which is a clear and obvious sign of failure in this industry) and released no human trial data really. CB-03-01 would have been amazing but it's so weak that even when applied twice a day the efficacy dropped significantly between 6-12 months. Follicia is essentially just micro-needling with an unknown compound that likely has to go through many phases of clinical trials that haven't even started. Topical finasteride will go systemic as it always has. SM04554 hasn't given any numbers to back up anything and their pace is pretty laughable. I'll leave out the rest of the treatments that have been dead for a long time now: Histogen, Aclaris, ext.. Is their seriously not a single reasonable hope for anything in the next 5-10 years. This is very depressing and I hope I missed something. What is there to look forward to that hasn't completely fallen over at this point. I'm hoping someone can prove me wrong and give me something to hope for.